Zobrazeno 1 - 10
of 101
pro vyhledávání: '"Irene Hramiak"'
Autor:
Lawrence A. Leiter, Stephen C. Bain, Irene Hramiak, Esteban Jódar, Sten Madsbad, Theis Gondolf, Thomas Hansen, Ingrid Holst, Ildiko Lingvay
Publikováno v:
Cardiovascular Diabetology, Vol 18, Iss 1, Pp 1-12 (2019)
Abstract Background The SUSTAIN 6 trial demonstrated that once-weekly semaglutide (0.5 and 1.0 mg) significantly reduced major adverse cardiovascular (CV) events (MACE) vs placebo in subjects with type 2 diabetes (T2D) and high CV risk. The effects o
Externí odkaz:
https://doaj.org/article/fe71e6d6a8614c3f877bea8458d69b7a
Autor:
Kristin K Clemens, Salimah Shariff, Kuan Liu, Irene Hramiak, Jeffrey L Mahon, Eric McArthur, Amit X Garg
Publikováno v:
PLoS ONE, Vol 10, Iss 9, p e0137596 (2015)
Over the last decade, several new antihyperglycemic medications have been introduced including those associated with a lower hypoglycemia risk. We aimed to investigate how these medications are being prescribed to older adults in our region.We conduc
Externí odkaz:
https://doaj.org/article/738aa14758074cfe82cbebc48d6f3670
Autor:
Jean-François Yale, Aude Roborel de Climens, Naresh Aggarwal, Terry Dex, Hertzel C. Gerstein, Stewart Harris, Irene Hramiak, John Stewart, Lawrence A. Leiter
Publikováno v:
Diabetes Therapy. 14:377-386
For people with type 2 diabetes mellitus who do not achieve glycated hemoglobin A1C targets after treatment with basal insulin therapies, additional therapy with a glucagon-like peptide-1 receptor agonist (GLP-1 RA) may be required. One option is to
Autor:
Irene Hramiak, Hertzel C. Gerstein, Lawrence A. Leiter, Jean‐François Yale, Harpreet S. Bajaj, John Stewart, Marie‐Josée Toutounji, Stewart B. Harris
Publikováno v:
Diabetes, Obesity and Metabolism. 24:1998-2007
To compare the efficacy and safety of a simple daily titration algorithm compared with a weekly dose adjustment of iGlarLixi in people with type 2 diabetes.LixiLan ONE CAN (NCT03767543), a randomized, 26-week, open-label, multicentre phase 3 trial co
Autor:
Medha Munshi, Robert Ritzel, Irene Hramiak, Gagik Galstyan, Elisabeth Souhami, Terry Dex, Lydie Melas-Melt, Julio Rosenstock
Publikováno v:
Metabolism. 142:155429
Autor:
Irene Hramiak, Hertzel C. Gerstein, Thorsten Siegmund, Lawrence A. Leiter, Jean-François Yale, Harpreet Bajaj, John Stewart, Marie-Josée Toutounji, Stewart B. Harris
Publikováno v:
Hand in Hand zum Ziel – einfach.besser.messbar www.diabeteskongress.de.
Autor:
null Irene Hramiak, null Hertzel C. Gerstein, null Lawrence A. Leiter, null Jean‐François Yale, null Harpreet S. Bajaj, null John Stewart, null Marie‐Josée Toutounji, null Stewart B. Harris
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6fbccb452f386d75c06a7265285f606
https://doi.org/10.1111/dom.14787/v2/response1
https://doi.org/10.1111/dom.14787/v2/response1
Autor:
Selina Liu, Melody Lam, Alexandra Ouedraogo, Tamara Spaic, Jeffrey Mahon, Irene Hramiak, Kristin Clemens
Publikováno v:
Canadian Journal of Diabetes. 46:S20
Autor:
Selina Liu, John Gonder, Ehsan Owrangi, Neil Klar, Irene Hramiak, Artem Uvarov, Jeffrey Mahon
Publikováno v:
Canadian Journal of Diabetes. 46:S27
Autor:
the REMIT-sita Collaborative Group, Hertzel C. Gerstein, Yan Yun Liu, Diana Sherifali, Ada Smith, Rose Otto, Farah Sultan, Vincent Woo, Manoela Braga, Remi Rabasa-Lhoret, Nikhil Gupta, Ronald Goldenberg, Ronald J. Sigal, Irene Hramiak, Stephanie Hall, Natalia McInnes
Objective The aim of the study was to evaluate remission of type 2 diabetes following a short-term intervention with insulin glargine, sitagliptin/metformin and lifestyle approaches. Research Design and Methods In this open multicenter trial, 102 pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0fb5fb4d542a2954d9cd6efc759f0f9f
https://doi.org/10.2337/figshare.16709122
https://doi.org/10.2337/figshare.16709122